ALKS vs DOCS

ALKS exhibits a weak Piotroski F-Score of 4/9, indicating marginal financial health, and lacks an Altman Z-Score, raising concerns about default risk. Despite a strong Graham Number of $18.80 and intrinsic value estimate of $10.01, the current price of $27.76 trades at a significant premium, especially given deteriorating growth and profitability metrics. The company shows a sharp decline in revenue and earnings (YoY: -10.6% and -67.0%), with recent quarterly earnings missing expectations and negative Q/Q trends. Insider selling activity over the past six months further undermines confidence, despite strong historical earnings surprises. The market appears to be pricing in future recovery, but current fundamentals suggest caution.

Doximity exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet characterized by near-zero debt. Despite elite gross margins (89.75%) and strong liquidity, the company is experiencing a severe valuation correction with a 1-year price decline of 57.4% and negative earnings growth (-16.20%). The current price of $24.01 trades at a significant premium to its Graham Number ($11.91) and Intrinsic Value ($8.33), indicating a disconnect between fundamental defensive value and market pricing. While analyst targets remain bullish, the combination of negative earnings momentum and bearish insider activity suggests caution.